ARTICLE | Clinical News
Micellar paclitaxel: Completed Phase II study enrollment
March 5, 2001 8:00 AM UTC
Angiotech Pharmaceuticals Inc. (ANPI; TSE:ANP), Vancouver, B.C. Product: Micellar paclitaxel Business: Autoimmune/Inflammation, Neurological Therapeutic category: Cytotoxic Target: Microtubules Descri...